QA: Celgene CORP DE in us_pharma/2015

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000816284_2016_Celgene_CORP_DE.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0000816284, Celgene CORP DE

  xvar xval
0 AssetsCurrent 9,400,900,000
1 IntangibleAssetsNetIncludingGoodwill 15,737,100,000
2 PropertyPlantAndEquipmentNet 814,100,000
3 remainder_Assets 1,101,300,000
4 LiabilitiesCurrent 1,968,900,000
5 LiabilitiesNoncurrent 16,292,100,000
6 remainder_Liabilities 2,873,400,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 2,395,950,064
9 ResearchAndDevelopmentExpense 4,047,615,503
10 remainder_Expenses 2,172,852,331
11 remainder_Revenues 9,820,964,232
12 remainder_NetIncome 167,789,851
13 remainder_ComprehensiveNetIncome 817,232,021
  yvar yval
0 Assets 27,053,400,000
1 Liabilities 21,134,400,000
2 Expenses 8,616,417,898
3 Revenues 9,820,964,232
4 StockholdersEquity 5,919,000,000
5 NetIncome 1,372,336,185
6 ComprehensiveNetIncome 1,780,952,196
7 BaseVar 33,805,102,001
8 EconomicCapitalRatiobeforeLimitedLiability 0.609
9 EconomicCapitalRatio 1.98

Edgar->Model Mapping

Feature Distribution

Change over Time